QBE North America Introduces Life Sciences Insurance Offering

Rhea-AI Summary

QBE North America (OTC:QBIEY) has launched a comprehensive Life Sciences insurance product designed to protect medical product developers, manufacturers, and distributors. The new offering provides liability coverage across multiple areas including clinical trials, dental and medical devices, specialty pharmaceuticals, and animal health products.

The product features primary and excess liability coverages including products completed operations, clinical trial liability, errors and omissions, general liability, and healthcare professional liability. This launch follows QBE's 2024 introduction of Miscellaneous Medical Liability products and expands their Healthcare Liability portfolio. In 2024, QBE North America reported Gross Written Premiums of $7.3 billion.

NEW YORK, July 8, 2025 /PRNewswire/ -- QBE North America announced today the launch of a Life Sciences product offering designed to address the complex and evolving risks faced by medical product developers, manufacturers and distributors. 

"Life sciences companies face a unique and fast-changing risk landscape," said Lisa McCormack, vice president, underwriting leader – Life Sciences, QBE North America. "Our new offering is tailored to meet the specific coverage needs of these businesses as they continue to innovate and advance health care."

The Life Sciences product provides liability protection for a wide range of classifications, including clinical trials, dental and medical devices, personal care, specialty pharmaceuticals, animal health products, and more.

QBE offers primary and excess Life Sciences liability coverages such as:

• Products completed operations
• Clinical trial liability
• Errors and omissions (E&O)
• General liability
• Healthcare professional liability

"Our new Life Sciences product offers flexible and comprehensive coverage," said John Livatino, senior vice president, head of Healthcare Liability, QBE North America. "By leveraging our suite of Healthcare Liability solutions, we can also expand coverage for life sciences companies to include areas like medical professional liability and technology. Whether it's Life Sciences, Digital Health or Miscellaneous Medical Liability, we're committed to providing a comprehensive insurance solution to these organizations."

The launch expands QBE's Healthcare Liability portfolio following the introduction of its Miscellaneous Medical Liability product in 2024. That offering includes coverages for professional liability, physical & sexual misconduct liability, general liability, employee benefits liability, E&O, tech & media liability and excess/umbrella.

More information about QBE's Life Sciences product is available at qbe.com/us/healthcare-liability. 

About QBE North America

QBE North America is a global insurance leader helping customers solve unique risks, so they can stay focused on their future. Part of QBE Insurance Group Limited, QBE North America reported Gross Written Premiums in 2024 of $7.3 billion. QBE Insurance Group's results can be found at qbe.com. Headquartered in Sydney, Australia, QBE operates out of 26 countries around the globe, with a presence in every key insurance market. The North America division, headquartered in New York, conducts business primarily through its insurance company subsidiaries. The actual terms and conditions of any insurance coverage are subject to the language of the policies as issued. Additional information can be found at qbe.com/us or follow QBE North America on LinkedIn, Facebook and Instagram

View original content to download multimedia:https://www.prnewswire.com/news-releases/qbe-north-america-introduces-life-sciences-insurance-offering-302500214.html

SOURCE QBE North America

FAQ

What new insurance products did QBE North America (QBIEY) launch in 2025?

QBE North America launched a comprehensive Life Sciences insurance product offering liability protection for medical product developers, manufacturers, and distributors, covering areas like clinical trials, medical devices, and specialty pharmaceuticals.

What types of coverage does QBE's new Life Sciences insurance product include?

The product includes primary and excess liability coverages for products completed operations, clinical trial liability, errors and omissions (E&O), general liability, and healthcare professional liability.

What was QBE North America's Gross Written Premium in 2024?

QBE North America reported Gross Written Premiums of $7.3 billion in 2024.

What industries are covered under QBE's new Life Sciences insurance offering?

The insurance covers clinical trials, dental and medical devices, personal care, specialty pharmaceuticals, and animal health products industries.

How does the 2025 Life Sciences product launch relate to QBE's previous insurance offerings?

The Life Sciences launch expands QBE's Healthcare Liability portfolio, following their 2024 introduction of Miscellaneous Medical Liability products.